TARS compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name

TARSTarsus Pharmaceuticals, Inc.

Mkt capRevenueRevenue

AMGNAmgen Inc

Mkt capRevenueRevenue

Compare

TARSTarsus Pharmaceuticals, Inc.

AMGNAmgen Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only TARS 6

ELANElanco Tiergesundheitsupplier

—Elancounlistedsupplier

—LianBio Ophthalmologyunlistedcustomer

—Xi An Grand Chang An Pharmaceuticalunlistedcustomer

2 more · TARS chain ›

Shared 0

No shared counterparties.

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

8 more · AMGN chain ›

TARSTarsus Pharmaceuticals, Inc.

67.46· pre 66.23· delayed

Mkt cap$3.4BRevenue$195MQ3 FY26Revenue$451MFY25

AMGNAmgen Inc

461.49· pre 460.22· delayed

Pre-marketNov 5 '26delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

Compare

Pre-marketNov 5 '26delayed

TARSTarsus Pharmaceuticals, Inc.

AMGNAmgen Inc

67.46pre 66.23delayed

Price

461.49pre 460.22delayed

$3.4B

Mkt cap

$249.0B

Q3 FY26$195M

Revenue

$10.4BQ3 FY26

FY25$451M

Revenue

$36.8BFY25

TARS67.46vsAMGN461.49Pre-marketNov 5 '26delayed